Pediatrix Medical Group has ridden a powerful share price run, with the stock now trading at US$31.62 and earnings firmly under the microscope. After such a move, investors are increasingly asking whether the current valuation still lines up with what the business is earning today. Over the past 3 years the stock has returned 226.7%, which puts a lot of emphasis on whether that kind of share price change is supported by the underlying profit stream. Recent earnings outperformance alongside...
Pediatrix Medical Group reported third quarter 2026 revenue of US$501.37 million with net income of US$46.99 million and diluted EPS from continuing operations of US$0.59, alongside nine month revenue of US$1.47 billion and diluted EPS of US$1.43. The latest results show revenue and earnings moving in different directions. Together with portfolio and cost pressures, this highlights how Pediatrix Medical Group is balancing demand for specialized pediatric care with profitability and...
FORT LAUDERDALE, Fla., October 20, 2026--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
Pediatrix Medical Group (MD) has drawn fresh attention after trading around a recent close of US$25.93. Investors are weighing this level against the company’s longer term return record and its current healthcare services footprint. Recent trading has been choppy for Pediatrix Medical Group, with a 1-day share price return of 1.73% offsetting some of the pressure from a 7-day share price return that slipped 3.64%. At the same time, the year-to-date share price return of 21.79% and a 1-year...
On August 4, Pediatrix Medical Group (NYSE:MD) reported second-quarter results that look strong on the surface. Adjusted earnings per share jumped to $0.63 from $0.53, and net revenue grew to $487.8 million. But look past the headline numbers, and the growth is coming largely from pricing and a shrinking share count, not from more patients […]
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Looking back on healthcare providers & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Pediatrix Medical Group (NYSE:MD) and its peers.
Detailed price information for Pediatrix Medical Group Inc (MD-N) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.